Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal adenocarcinoma, esophageal cancer, esophageal disorder, neoplasm	Active, not recruiting	Not stated	2024-11-12		NCT06642506

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany	3
Ludwig-Maximilians - University of Munich	67
Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, MÃ¼nchen, Germany	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of General, Visceral and Transplantation Surgery, LMU University Hospital	Munich	Germany	1